Showing results (3601-3610 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 18, 2007
Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinationsEnrico Garattini, Maurizio Gianni, Mineko TeraoCurrent Pharmaceutical Design|April 14, 2007
Animal models to study plaque vulnerabilityK Schapira, S Heeneman, M J A P DaemenCurrent Pharmaceutical Design|April 14, 2007
Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?Fatima Akdim, Sander I van Leuven, John J P Kastelein, et al.Current Pharmaceutical Design|April 14, 2007
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular diseaseJan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, et al.Current Pharmaceutical Design|April 14, 2007
Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?A O Kraaijeveld, S C A de Jager, T J C van Berkel, et al.Current Pharmaceutical Design|April 14, 2007
Multi-constituent cardiovascular pills (MCCP)--challenges and promises of population-based prophylactic drug therapy for prevention of heart attackMichael J Jamieson, Morteza NaghaviCurrent Pharmaceutical Design|April 14, 2007
NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosisJorge Busciglio, Alejandra Pelsman, Pablo Helguera, et al.Current Pharmaceutical Design|April 14, 2007
Food-derived peptides and intestinal functionsMakoto Shimizu, Dong Ok SonCurrent Pharmaceutical Design|April 14, 2007
Cytotoxic and allergenic potential of bioactive proteins and peptidesRainer Hartmann, Jean-Michel Wal, Hervé Bernard, et al.Current Pharmaceutical Design|May 27, 2006
Recent progress in the design of small molecule inhibitors of HIV RNase HKlaus Klumpp, Tara MirzadeganPageof 1,008